Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1983-02-07
1986-07-22
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 10, 544 50, 2609982, 546147, 546165, 546245, 546341, 548186, 548188, 548201, 548379, 548408, 548452, 548491, 548899, 548532, A61K 31405, A61K 3702, C07D20708
Patent
active
046020020
ABSTRACT:
Compounds of the formula: ##STR1## wherein R.sup.2 is --(CH.sub.2).sub.k --X--(CH.sub.2).sub.j --NHR.sup.3 ; wherein k is 0 to 3, j is 1 or 2; X is F or OH; and, R.sup.3 is hydrogen; loweralkyl or loweraralkyl which may be substituted by hydroxy, carboxy, carbamoyl, or carbalkoxy; or, acyl; and, a pharmaceutically acceptable salt thereof; are inhibitors of angiotensin I converting enzyme useful as antihypertensive agents.
REFERENCES:
patent: 4470973 (1984-09-01), Natarajan et al.
Patchett Arthur A.
Wu Mu T.
Hollrah Glennon H.
Merck & Co. , Inc.
Mitri Salvatore C.
Sudol Michael C.
Turnipseed James H.
LandOfFree
N-carboxymethyl substituted lysyl and .alpha.-(.epsilon.-aminoal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-carboxymethyl substituted lysyl and .alpha.-(.epsilon.-aminoal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-carboxymethyl substituted lysyl and .alpha.-(.epsilon.-aminoal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-866134